Why is AtriCure, Inc. ?
- The company has declared positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 64.94 MM
- ROCE(HY) Highest at 2.15%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- Over the past year, while the stock has generated a return of 15.29%, its profits have risen by 81.8%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to AtriCure, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AtriCure, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 64.94 MM
Highest at 2.15%
The company hardly has any interest cost
Fallen by -3.8% (YoY
Lowest at -18.73 %
Highest at USD 153.6 MM
Highest at USD 14.97 MM
Highest at 9.75 %
Highest at USD 9.43 MM
Highest at USD 8.96 MM
Highest at USD 0.18
Lowest at 7.8 times
Here's what is working for AtriCure, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for AtriCure, Inc.
Debtors Turnover Ratio






